[{"Assets_0_FY_USD":33551000000.0,"EarningsPerShareBasic_1_FY_USD":-1.42,"EarningsPerShareBasic_4_FY_USD":0.61,"EarningsPerShareDiluted_1_FY_USD":-1.42,"EarningsPerShareDiluted_4_FY_USD":0.61,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":5275000000.0,"NetIncomeLoss_1_FY_USD":-2328000000.0,"NetIncomeLoss_4_FY_USD":1007000000.0,"StockholdersEquity_0_FY_USD":11741000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":1652000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1645000000.0,"Ticker":"BMY","CIK":"14272","name":"BRISTOL MYERS SQUIBB CO","OfficialName":"Bristol-Myers Squibb Company Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"162365472986.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"SP500","filed":"20180213"}]